4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-25-097594
Chief Financial Officer bought 10,870 shares at $9.09 ($98,808)
From the SEC's structured data for this filing
Trades in this filing
Bodenstedt Matthias · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-08 | Purchase : show line 1 in the form | +10,870 | $9.09 | $98,808 | 627,536 | D |
| Open-market purchases · 10,870 sh · avg $9.09 · $98,808 | ||||||
Loading xslF345X05/ownership.xml…